Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05338346
Title A Study of ATG-018 (ATR Inhibitor) Treatment in Patients With Advanced Solid Tumors and Hematological Malignancies (ATRIUM)
Acronym ATRIUM
Recruitment Terminated
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors Antengene Discovery Limited
Indications
Therapies
Age Groups: senior | adult
Covered Countries AUS

Facility Status City State Zip Country Details
Icon Cancer Centre South Brisbane Brisbane Australia Details
Chris O'Brien Lifehouse Camperdown Australia Details
Austin Health Heidelberg Australia Details
Alfred Health Melbourne Australia Details
Liverpool Hospital Sydney Australia Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field